Once you're a member, here's what can become part of your plan always after the evaluation, the labs, and your consultant's recommendation confirm it's right for you
Under the terms of its new agreement, Hims will officially stop advertising its compounded GLP-1s to customers, while current patients will have the opportunity to transition to FDA-approved medicines, the company stated Monday
it's an investment in your overall well-being
Does PlexusDx work with patients taking prednisone
Qualifying reasons under 503A include: Allergy to phenol or another preservative in the commercial formulation Need for a dose strength not commercially available (e.g., 1.5 mg, which falls between Ozempic's 1 mg and 2 mg pens) Inability to use the pen injector device due to dexterity issues (though this is weak because vial-and-syringe versions could theoretically be requested from Novo Nordisk) The FDA has historically taken a narrow view of what constitutes a legitimate patient-specific need, and "I prefer the compounded version" or "the commercial version is too expensive" do not qualify
This week, The Pharmaceutical Journal has reported on Mounjaro (tirzepatide
